MSCA-ITN-2014-ETN
MSCA-ITN-2014-ETN
Programme: H2020
107 projects · €376,667,819 total EU contribution (project-level) · 1058 participating organizations · 53 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€376,667,819
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (191)
- UK (154)
- Netherlands (83)
- Spain (80)
- France (77)
- Italy (66)
- BE (43)
- SE (33)
- CH (32)
- DK (28)
- AT (24)
- PT (23)
- US (20)
- EL (19)
- FI (19)
- HU (16)
- IE (16)
- IL (14)
- CZ (13)
- NO (12)
- CA (9)
- AU (6)
- IS (6)
- PL (5)
- RU (5)
- EE (4)
- LT (4)
- SI (4)
- AR (3)
- CN (3)
- JP (3)
- LU (3)
- TR (3)
- BG (2)
- GE (2)
- KR (2)
- LV (2)
- NZ (2)
- RO (2)
- RS (2)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CNRS19 projects · FR
- KU Leuven12 projects · BE
- UNIVERSITY COLLEGE LONDON12 projects · UK
- UU11 projects · NL
- UCPH10 projects · DK
- TU/e10 projects · NL
- EPFL9 projects · CH
- ETH Zürich9 projects · CH
- MPG9 projects · DE
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE9 projects · UK
- TECHNICAL UNIVERSITY OF DENMARK DTU8 projects · DK
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE8 projects · UK
Projects
Page 5 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Improving Design, Evaluation and Analysis of early drug development Studies IDEAS · 633567 | H2020 | €3,108,939 | €250,560 | Details |
Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells IMMUNOSHAPE · 642870 | H2020 | €3,811,581 | €249,216 | Details |
Critical Transitions in Complex Systems CRITICS · 643073 | H2020 | €3,896,688 | €249,216 | Details |
Integrated view on disruptions of early brain development BRAINVIEW · 642996 | H2020 | €3,888,945 | €546,576 | Details |
Rapid Bioprocess Development Biorapid · 643056 | H2020 | €4,038,972 | €290,082 | Details |
Biochemical and mechanochemical mechanisms in polarized cells BIOPOL · 641639 | H2020 | €3,911,897 | €498,433 | Details |
SupramolecularlY eNgineered arCHitectures for optoelectRonics and photONICS: a multi-site initial training action SYNCHRONICS · 643238 | H2020 | €3,650,589 | €249,216 | Details |
European Training Network to Accelerate the Development Chain of Nanostructured Polymers TheLink · 642890 | H2020 | €3,794,899 | €0 | Details |
Head protection: a European training network for Advanced Designs in Safety HEADS · 642662 | H2020 | €3,387,266 | €751,680 | Details |
VPH-Cardiovascular Simulation and Experimentation for Personalised Medical Devices VPH-CaSE · 642612 | H2020 | €3,700,187 | €0 | Details |